Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01519232 · ClinicalTrials.gov registry record
A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
NCT01519232 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 23 participants.
The verdict
NCT01519232 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Radiation-induced liver disease (RILD) is a syndrome characterized by the development of anicteric ascites approximately 2 weeks to 4 months after hepatic irradiation. Previous studies have shown that both the volume of liver irradiated and the dose of radiation delivered are prominent factors for development of RILD. While use of a population-based normal tissue complication probability model allows investigators to limit the risk of RILD to a clinically acceptable level, a test that permits investigators to determine an individual's risk of RILD during the course of treatment may allow for individualized treatment modifications, either to prevent toxicity or increase efficacy.
Interventions
- RADIATION Liver Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01519232
The ClinicalTrials.gov registry entry for NCT01519232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liver Irradiation is the first listed.
NCT01519232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01519232 about?
NCT01519232 is a clinical study titled "A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)". Radiation-induced liver disease (RILD) is a syndrome characterized by the development of anicteric ascites approximately 2 weeks to 4 months after hepatic irradiation. Previous studies have shown that both the volume of liver irradiated and the dose of radiation delivered are prominent factors for d...
What is the current status of trial NCT01519232?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2008-08. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01519232?
The interventions under investigation include: Liver Irradiation (RADIATION).
Who is sponsoring clinical trial NCT01519232?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.